Form D · Biotechnology

OncoMed Pharmaceuticals Inc

Redwood City, CA · CIK 0001302573

Offering snapshot reported Dec 6, 2013 · SEC filing

Reported sold
$22.2M
Offering amount: $22.2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 3, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 6, 2013Initial$22,249,996No comparison1SEC filing
Jan 7, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Aug 21, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-207569

Source: Form D, filed Dec 6, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Broderick Director
Jakob Dupont Executive
Terry Gould Director
Austin Gurney Executive
Alicia J. Hager Executive
Paul J. Hastings Director, Executive
Timothy Hoey Executive
Jack Lasersohn Director
Larry Lasky Director
John A. Lewicki Executive
Deepa Pakianathan Director
Sunil Patel Executive
Denise Pollard Knight Director
Jonathan Root Director
William D. Waddill Executive
Jim Woody Director
Michael Wyzga Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
800 Chesapeake Drive
Redwood City, CA, 94063